{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:55:55Z","timestamp":1792061755573,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":320,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Medical Sciences Journal"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.24920\/004447","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T21:44:33Z","timestamp":1750715073000},"page":"132-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causal Relationships Between Mineralocorticoid Receptor Activation and Tubulointerstitial Nephritis and Lipid Metabolism Dysregulation: A Mendelian Randomization Study"],"prefix":"10.1016","volume":"40","author":[{"given":"Min","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.24920\/004447_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur Heart J"},{"issue":"9","key":"10.24920\/004447_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097719","article-title":"Mineralocorticoid receptor antagonists for preventing chronic kidney disease progression: current evidence and future challenges","volume":"24","author":"Fujii","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.24920\/004447_bib3","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: reninangiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","journal-title":"Circ Res"},{"issue":"12","key":"10.24920\/004447_bib4","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/ndt\/10.12.2192","article-title":"Increased renal expression of cytokines and growth factors induced by DOCA-NaCl treatment in Heymann nephritis","volume":"10","author":"Tikkanen","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.24920\/004447_bib5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J Clin Invest"},{"issue":"Pt 2","key":"10.24920\/004447_bib6","first-page":"F781","article-title":"Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron","volume":"264","author":"Todd-Turla","year":"1993","journal-title":"Am J Physiol"},{"key":"10.24920\/004447_bib7","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1681\/ASN.2004090804","article-title":"Regression of existing glomerulosclerosis by inhibition of aldosterone","volume":"16","author":"Aldigier","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.24920\/004447_bib8","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat Med"},{"key":"10.24920\/004447_bib9","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","article-title":"Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus","volume":"147","author":"Guo","year":"2006","journal-title":"Endocrinology"},{"key":"10.24920\/004447_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/HYPERTENSIONAHA.121.17263","article-title":"Activation of Rac1-mineralocorticoid receptor pathway contributes to renal injury in salt-loaded db\/db mice","volume":"78","author":"Hirohama","year":"2021","journal-title":"Hypertension"},{"issue":"6","key":"10.24920\/004447_bib11","first-page":"606","article-title":"The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomerulonephritis","volume":"4","author":"Zitt","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"10.24920\/004447_bib12","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1681\/ASN.2012111094","article-title":"Myeloid mineralocorticoid receptor activation contributes to progressive kidney disease","volume":"25","author":"Huang","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"Pt 2","key":"10.24920\/004447_bib13","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/01.ju.0000140445.82949.54","article-title":"Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction","volume":"172","author":"Trachtman","year":"2004","journal-title":"J Urol"},{"key":"10.24920\/004447_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000473702","article-title":"The inhibitory effect of eplerenone on cell proliferation in the contralateral kidneys of rats with unilateral ureteral obstruction","volume":"136","author":"Wang","year":"2017","journal-title":"Nephron"},{"key":"10.24920\/004447_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1159\/000518254","article-title":"Direct blood pressure-independent anti-fibrotic effects by the selective nonsteroidal mineralocorticoid receptor antagonist finerenone in progressive models of kidney fibrosis","volume":"52","author":"Droebner","year":"2021","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.24920\/004447_bib16","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"10.24920\/004447_bib17","doi-asserted-by":"crossref","first-page":"F556","DOI":"10.1152\/ajprenal.00332.2016","article-title":"NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury","volume":"312","author":"Bai","year":"2017","journal-title":"Am J Physiol Physiol"},{"key":"10.24920\/004447_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203823","article-title":"The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice","volume":"13","author":"Sogawa","year":"2018","journal-title":"PLoS ONE"},{"key":"10.24920\/004447_bib19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.kint.2017.12.016","article-title":"The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling","volume":"93","author":"Barrera-Chimal","year":"2018","journal-title":"Kidney Int"},{"key":"10.24920\/004447_bib20","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1159\/000339500","article-title":"Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K\/MAPK signalling","volume":"120","author":"Huang","year":"2012","journal-title":"Nephron Exp Nephrol"},{"key":"10.24920\/004447_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.kisu.2021.11.004","article-title":"Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease","volume":"12","author":"Nakamura","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"10.24920\/004447_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.kisu.2021.11.006","article-title":"The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis","volume":"12","author":"Luther","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"10.24920\/004447_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1681\/ASN.2008020232","article-title":"Aldosterone activates NF-\u03baB in the collecting duct","volume":"20","author":"Leroy","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.24920\/004447_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145946","article-title":"Aldosterone induces renal fibrosis and inflammatory M1-macrophage subtype via mineralocorticoid receptor in rats","volume":"11","author":"Mart\u00edn-Fernandez","year":"2016","journal-title":"PLoS ONE"},{"key":"10.24920\/004447_bib25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.121.17712","article-title":"Neutrophil gelatinase-associated lipocalin from macrophages plays a critical role in renal fibrosis via the CCL5 (chemokine ligand 5) -Th2 cells-IL4 (interleukin 4) pathway","volume":"79","author":"Bonnard","year":"2022","journal-title":"Hypertension"},{"issue":"2","key":"10.24920\/004447_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.mce.2011.09.011","article-title":"The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism","volume":"350","author":"Marzolla","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.24920\/004447_bib27","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"10.24920\/004447_bib28","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.24920\/004447_bib29","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.24920\/004447_bib30","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1096\/fj.202000164R","article-title":"The novel non-steroidal MR antagonist finerenone improves metabolic parameters in high-fat diet-fed mice and activates brown adipose tissue via AMPK-ATGL pathway","volume":"34","author":"Marzolla","year":"2020","journal-title":"FASEB J"},{"issue":"1","key":"10.24920\/004447_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13098-023-01064-3","article-title":"Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus","volume":"15","author":"Jin","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"10.24920\/004447_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tem.2019.11.006","article-title":"Mineralocorticoid receptors in metabolic syndrome: from physiology to disease","volume":"31","author":"Feraco","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"10.24920\/004447_bib33","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1096\/fj.13-245415","article-title":"Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice","volume":"28","author":"Armani","year":"2014","journal-title":"FASEB J"},{"issue":"5","key":"10.24920\/004447_bib34","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"issue":"D1","key":"10.24920\/004447_bib35","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","article-title":"The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019","volume":"47","author":"Buniello","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.24920\/004447_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"issue":"7708","key":"10.24920\/004447_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.24920\/004447_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med"},{"key":"10.24920\/004447_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73951","article-title":"Constructing an atlas of associations between polygenic scores from across the human phenome and circulating metabolic biomarkers","volume":"11","author":"Fang","year":"2022","journal-title":"eLife"},{"issue":"7571","key":"10.24920\/004447_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.24920\/004447_bib41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.24920\/004447_bib42","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41593-018-0206-1","article-title":"GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia","volume":"21","author":"Pasman","year":"2018","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.24920\/004447_bib43","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"issue":"11","key":"10.24920\/004447_bib44","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1172\/JCI45161","article-title":"Cellular pathophysiology of ischemic acute kidney injury","volume":"121","author":"Bonventre","year":"2011","journal-title":"J Clin Invest"},{"issue":"7944","key":"10.24920\/004447_bib45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"7","key":"10.24920\/004447_bib46","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"issue":"2","key":"10.24920\/004447_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.24920\/004447_bib48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"6","key":"10.24920\/004447_bib49","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.24920\/004447_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"7414","key":"10.24920\/004447_bib51","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.24920\/004447_bib52","first-page":"272","article-title":"Investigating the causal relationship between human blood metabolites and coronary artery disease using two-sample Mendelian randomization","volume":"41","author":"Wang","year":"2021","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.24920\/004447_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","article-title":"Mineralocorticoid receptors: distribution and activation","volume":"10","author":"Funder","year":"2005","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10.24920\/004447_bib54","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2011.11.026","article-title":"Aldosterone and mineralocorticoid receptors: a personal reflection","volume":"350","author":"Funder","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"18","key":"10.24920\/004447_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189995","article-title":"Mineralocorticoid receptor antagonists\u2014use in chronic kidney disease","volume":"22","author":"Baran","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.24920\/004447_bib56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2016.02.034","article-title":"Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor","volume":"1637","author":"Dinh","year":"2021","journal-title":"Brain Res"},{"issue":"1","key":"10.24920\/004447_bib57","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.24920\/004447_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease\u2014a 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2017","journal-title":"Acta Physiol"},{"key":"10.24920\/004447_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11883-009-0080-0","article-title":"Future therapeutic directions in reverse cholesterol transport","volume":"12","author":"Khera","year":"2010","journal-title":"Curr Atheroscler Rep"},{"key":"10.24920\/004447_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11883-012-0235-2","article-title":"High-density lipoprotein and atherosclerosis: the role of antioxidant activity","volume":"14","author":"Bandeali","year":"2012","journal-title":"Curr Atheroscler Rep"}],"container-title":["Chinese Medical Sciences Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001929425000240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001929425000240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/cmsj.cams.cn\/previewFile?fileName=Causal%20Relationships%20Between%20Mineralocorticoid%20Receptor%20Activation%20and%20Tubulointerstitial%20Nephritis%20and%20Lipid%20Metabolism%20Dysregulation%3A%20A%20Mendelian%20Randomization%20Study&id=88905284&type=pdf&lang=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:36:20Z","timestamp":1792060580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1001929425000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1001929425000240"],"URL":"https:\/\/doi.org\/10.24920\/004447","relation":{},"ISSN":["1001-9294"],"issn-type":[{"value":"1001-9294","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causal Relationships Between Mineralocorticoid Receptor Activation and Tubulointerstitial Nephritis and Lipid Metabolism Dysregulation: A Mendelian Randomization Study","name":"articletitle","label":"Article Title"},{"value":"Chinese Medical Sciences Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.24920\/004447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025 Chinese Academy Medical Sciences. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}